Abstract:Objective To verify the efficacy and safety of intravesical instillation of Cystistat in reducing complications caused by intravesical chemotherapy after TUR-BT in non-muscle invasive bladder cancer patients. Methods One hundred and twenty patients who met the inclusion/exclusion criteria were enrolled into this multi-centered, randomized and blank controlled clinical study. Selected patients were randomized into the observation group and control group. TUR-BT was carried out in both groups followed by pirarubicin (THP) and Cystistat intravesical instillation in the observation group, and THP intravesical instillation alone in control group. Visual analog scale (VAS) was used as the primary efficacy variable. The secondary efficacy variables were assessments of hematuria and bladder irritation symptoms. Adverse events, laboratory tests and changes of vital signs before and after treatment were strictly observed during observation to evaluate the efficacy and safety of Cystistat.Results Demographics and baseline characteristics were comparable in both groups. The differences and the improvement rate of VAS score in the 2 groups were significant, both P＜0.01. The changes of VAS score and the improvement rate before and after treatment were (2. 24±1.70) and (92. 92±14.76) % in observation group and (0. 70±1.82) and (20. 59±87.34)% in control group respectively. According to the covariance analysis, there were significant differences in changes of VAS score between the observation group and the control group. Also, the improvement rate of VAS score was significant from visit 2. The urine frequency decreased from 9.06±4.09 to 6. 69±2.89 in observation group and increased from 8. 85±3. 32 to 10. 15±4.40 in control group, P＜0.01. There were also significant differences in changes of nocturia before and after treatment between these two groups (P＜0.01), the nocturia decreased from 2. 88±1.74 to 1. 47±1.62 in observation group and 3. 22±2.30 to 2.91±1.73 in control group, respectively. The changes of WHO assessment for hematuria,urgency and dysuria were not significantly different between the 2 groups. No Cystistat related adverse event was observed. Conclusions Cystistat combined instillation can significantly improve the VAS score of patients with chemotherapeutic agent instillation. Relief of bladder pain, frequency and nocturia are more rapidly and more durable in Cystistat combined instillation group. The improvement is more effective in patients with a high VAS score. Cystistat instillation with chemotherapeutics agents is both well tolerated and safe.

The treatment of parapelvic cyst with color doppler ultrasound guided percutaneous puncture and absolute ethanol combined with biological fibrin glue

The Clinical Efficacy and Safety of Flexible Ureteroscopic Treatment for Parapelvic Renal Cyst and Secondary Renal Stone.

Percutaneous Color Doppler Ultrasonography-Guided Drainage and Sclerotherapy with Absolute Ethanol for Renal Cyst

[Ultrasound guided percutaneous puncture and sclerotherapy with alcohol for peripelvic cysts].

Clinical application of ultrasound-guided percutaneous lauromacrogol sclerotherapy for symptomatic uterine fibroids

The diagnostic value of female paraurethral cyst by transperineal and transvaginal sonography

Enucleation of Benign Ovarian Cysts by Laparoscopy

The Treatment of Cystitis Glandulaisi Wilh Transurelhral Resection Electrovaporization and Intravesical Per Fusion of Drugs (report of 25 Cases)

Repeated percutaneous sclerotherapy of an enormous pelvic cyst with absolute alcohol of flushing dose: Report of a case

CT Guided Interventional Therapy in Renal and Heptic Cysts

Comparative Study of Different Therapeutics Used for Simple Renal Cysts

Combination of Cystistat and Pirarubicin Intravesical Instillation in Reducing Intravesical Chemotherapy Complications: a Multi-Center Clinical Study

Treatment of huge hepatic cysts by CT-guided puncturing and injecting absolute alcohol

Efficacy and Safety of Alcohol Sclerotherapy Involving Single-Session Multiple Injections to Treat Simple Renal Cysts: A Multicenter, Prospective, Randomized, Controlled Trial

Study of Effect of Alcohol Sclerotherapy on Endometrial Cyst Guided by Ultrasound

Percutaneous Sclerotization of Simple Renal Cysts with 95% Ethanol Followed by 24–48 h Drainage with Nephrostomy Tube

Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts

Ultrasound-guided Percutaneous Ethanol Sclerotherapy of Simple Renal Cysts in Children

[Surgical Treatment of Severe, Refractory Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: a Report of 17 Patients].

Therapeutic Value of EUS-guided Dehydrated Ethanol Lavage for Pancreatic Cystic Neoplasms

Percutaneous Drainage of Simple Cysts of the Kidney: A New Method